Lenalidomide

This classification denotes a biological response modifier with the molecular formula C13H13N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) F0P408N6V4, chemically known as 2,6-piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2h-isoindol-2-yl)- but more generally known as lenalidomide, which bears US NIH Compound Identifier 216326. European Medicines Agency schedules Lenalidomide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25389. The term LENALIDOMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, No. 1, 2005, List 53). World Health Organization schedules lenalidomide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule lenalidomide under HS 29337900 and SITC 51561. As of Q4 2014, LENALIDOMIDE remains US FDA's Preferred Term for this commodity. Lenalidomide bears US NLM identifiers UMLS ID C1144149 and NCI Concept Code C2668. SMILES: O=C1N(C2CCC(=O)NC2=O)CC2C1CCCC2N.